105 related articles for article (PubMed ID: 10422941)
1. Fentanyl pharmacokinetics in hemorrhagic shock: a porcine model.
Egan TD; Kuramkote S; Gong G; Zhang J; McJames SW; Bailey PL
Anesthesiology; 1999 Jul; 91(1):156-66. PubMed ID: 10422941
[TBL] [Abstract][Full Text] [Related]
2. Influence of hemorrhagic shock on remifentanil: a pharmacokinetic and pharmacodynamic analysis.
Johnson KB; Kern SE; Hamber EA; McJames SW; Kohnstamm KM; Egan TD
Anesthesiology; 2001 Feb; 94(2):322-32. PubMed ID: 11176098
[TBL] [Abstract][Full Text] [Related]
3. Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis.
Johnson KB; Egan TD; Kern SE; McJames SW; Cluff ML; Pace NL
Anesthesiology; 2004 Sep; 101(3):647-59. PubMed ID: 15329589
[TBL] [Abstract][Full Text] [Related]
4. Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers.
Egan TD; Sharma A; Ashburn MA; Kievit J; Pace NL; Streisand JB
Anesthesiology; 2000 Mar; 92(3):665-73. PubMed ID: 10719944
[TBL] [Abstract][Full Text] [Related]
5. The influence of hemorrhagic shock on propofol: a pharmacokinetic and pharmacodynamic analysis.
Johnson KB; Egan TD; Kern SE; White JL; McJames SW; Syroid N; Whiddon D; Church T
Anesthesiology; 2003 Aug; 99(2):409-20. PubMed ID: 12883414
[TBL] [Abstract][Full Text] [Related]
6. The population pharmacokinetics of fentanyl in patients undergoing living-donor liver transplantation.
Jin SJ; Jung JY; Noh MH; Lee SH; Lee EK; Choi BM; Song MH; Noh GJ
Clin Pharmacol Ther; 2011 Sep; 90(3):423-31. PubMed ID: 21814196
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics of Fentanyl in the Critically Ill.
Choi L; Ferrell BA; Vasilevskis EE; Pandharipande PP; Heltsley R; Ely EW; Stein CM; Girard TD
Crit Care Med; 2016 Jan; 44(1):64-72. PubMed ID: 26491862
[TBL] [Abstract][Full Text] [Related]
8. Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.
Darwish M; Kirby M; Robertson P; Hellriegel E; Jiang JG
Clin Pharmacokinet; 2006; 45(8):843-50. PubMed ID: 16884321
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous assessment of drug interactions with low- and high-extraction opioids: application to parecoxib effects on the pharmacokinetics and pharmacodynamics of fentanyl and alfentanil.
Ibrahim AE; Feldman J; Karim A; Kharasch ED
Anesthesiology; 2003 Apr; 98(4):853-61. PubMed ID: 12657846
[TBL] [Abstract][Full Text] [Related]
10. A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach.
Encinas E; Calvo R; Lukas JC; Vozmediano V; Rodriguez M; Suarez E
Paediatr Drugs; 2013 Jun; 15(3):247-57. PubMed ID: 23657896
[TBL] [Abstract][Full Text] [Related]
11. An innovative phase I population pharmacokinetic approach to investigate the pharmacokinetics of an intranasal fentanyl spray in healthy subjects.
Plock N; Facius A; Hartmann L; Baumann S; Nave R
Int J Clin Pharmacol Ther; 2013 Jun; 51(6):495-508. PubMed ID: 23611571
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic model of subcutaneous fentanyl in older acute care patients.
Al-Qurain AA; Upton R; Williams DB; Mackenzie L; Phillips C; Russell PT; Tadros R; Roberts MS; Wiese MD
Eur J Clin Pharmacol; 2021 Sep; 77(9):1357-1368. PubMed ID: 33811491
[TBL] [Abstract][Full Text] [Related]
13. Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil.
Ummenhofer WC; Arends RH; Shen DD; Bernards CM
Anesthesiology; 2000 Mar; 92(3):739-53. PubMed ID: 10719953
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
Scholz J; Steinfath M; Schulz M
Clin Pharmacokinet; 1996 Oct; 31(4):275-92. PubMed ID: 8896944
[TBL] [Abstract][Full Text] [Related]
15. Remifentanil pharmacokinetics in obese versus lean patients.
Egan TD; Huizinga B; Gupta SK; Jaarsma RL; Sperry RJ; Yee JB; Muir KT
Anesthesiology; 1998 Sep; 89(3):562-73. PubMed ID: 9743391
[TBL] [Abstract][Full Text] [Related]
16. Validation of fentanyl pharmacokinetics in patients undergoing coronary artery bypass grafting.
Hudson RJ; Thomson IR; Henderson BT; Singh K; Harding G; Peterson DJ
Can J Anaesth; 2002 Apr; 49(4):388-92. PubMed ID: 11927479
[TBL] [Abstract][Full Text] [Related]
17. Factors Contributing to Fentanyl Pharmacokinetic Variability Among Diagnostically Diverse Critically Ill Children.
Hagos FT; Horvat CM; Au AK; Conley YP; Li L; Poloyac SM; Kochanek PM; Clark RSB; Empey PE
Clin Pharmacokinet; 2019 Dec; 58(12):1567-1576. PubMed ID: 31168770
[TBL] [Abstract][Full Text] [Related]
18. Fentanyl clearance and volume of distribution are increased in patients with major burns.
Han T; Harmatz JS; Greenblatt DJ; Martyn JA
J Clin Pharmacol; 2007 Jun; 47(6):674-80. PubMed ID: 17428913
[TBL] [Abstract][Full Text] [Related]
19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics.
Yassen A; Olofsen E; Dahan A; Danhof M
J Pharmacol Exp Ther; 2005 Jun; 313(3):1136-49. PubMed ID: 15701707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
